Trials / Completed
CompletedNCT00483665
Vasovist Endoleak Study
Detection of Endoleak by Vasovist-Enhanced Magnetic Resonance Imaging
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- UMC Utrecht · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
After endovascular treatment of an abdominal aortic aneurysm, lifelong imaging follow-up is needed to monitor the effectiveness of the treatment. One parameter in this follow-up is endoleak, which is leakage of blood into the aneurysm sac. The aim of this study is to investigate the value of magnetic resonance imaging using Vasovist as a contrast agent for the detection of endoleaks.
Detailed description
After endovascular abdominal aortic aneurysm repair, life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow. For this reason, aneurysm diameter and the presence of endoleaks is evaluated with computed tomographic (CT) angiography yearly after Endovascular Aneurysm Repair (EVAR). The aim of this study is to investigate the value of magnetic resonance imaging using Vasovist as a contrast agent for the detection of endoleaks. The advantages of magnetic resonance imaging with respect to CTA are no use of ionizing radiation, use of less nephrotoxic contrast agents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Computed tomography angiography | Computed tomography angiography |
| PROCEDURE | Magnetic resonance imaging | Magnetic resonance imaging after injection of Vasovist |
Timeline
- Start date
- 2006-06-01
- First posted
- 2007-06-07
- Last updated
- 2008-11-19
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00483665. Inclusion in this directory is not an endorsement.